By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

bioMerieux, Inc. 

1022 Higham Street

Rockland  Maryland  02370  U.S.A.
Phone: 800-638-4835 Fax:


SEARCH JOBS




Collaborations

Gen-Probe Incorporated (Acquired by Hologic)  In September 2004, Gen-Probe entered into non-exclusive licensing agreements with bioMérieux and its affiliates that provide bioMérieux options to access our ribosomal RNA technologies to develop diagnostic products for certain disease targets.





Company News
bioMerieux, Inc.'s THxID®-BRAF Test For Detection Of 2 BRAF Mutations V600E And V600K In Late-Stage Metastatic Melanoma Adopted By Clarient, Inc., A GE Healthcare Company 1/29/2014 10:49:42 AM
Quanterix Raises $18.5 Million, Inks Deal With bioMerieux, Inc. 11/16/2012 7:06:53 AM
Thermo Fisher Scientific (TMO) and bioMerieux, Inc. Renew Partnership for Improved Detection of Sepsis Using PCT Biomarker 10/2/2012 9:54:32 AM
bioMerieux, Inc. Sticks to Sales Growth Goal 4/25/2012 8:36:41 AM
bioMerieux, Inc. Release: World HAI Forum: Global Call to Action to Fight Antibiotic Resistance 6/30/2011 7:13:16 AM
bioMerieux, Inc. Launches Groundbreaking Salmonella Detection Technology to Improve Food Safety 6/22/2011 8:54:16 AM
bioMerieux, Inc. Buys Microbiological Analysis Firm AES for $260 Million 5/26/2011 9:28:02 AM
bioMerieux, Inc. Receives FDA Clearance for NucliSENS EasyQ(R) MRSA, Automated, Rapid Molecular Screening Test 5/25/2011 7:06:07 AM
bioMerieux, Inc. Expands Global Recall for Anti-Bacterial Tests 4/13/2011 8:57:56 AM
Ipsen and bioMerieux, Inc. Enter into a Broad Partnership in Personalized Medicine 2/25/2011 6:19:57 AM
12345678
//-->